Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FZS84
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,138
Award facts
- Contract value 100% obligated
- $37,137.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $37,137.60 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml syringes. This delivery order, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a direct fulfillment of pharmaceutical needs for Department of Defense healthcare facilities. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation, competing on its established capabilities within the federal pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500 million and valid through November 2026. The IDC authorizes the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military health facilities worldwide. Xolair, a biologic medication used for asthma and allergic conditions, aligns with the IDC's scope covering specialty pharmaceutical products and supports the Defense Logistics Agency's mission to supply essential medications to the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DB25FZS84?
SPE2DB25FZS84 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FZS84 worth?
The government has obligated $37,138 on SPE2DB25FZS84.
Is contract SPE2DB25FZS84 an order under another contract?
Yes. SPE2DB25FZS84 is a delivery order under SPE2DB22D9244, an indefinite delivery contract.
Was contract SPE2DB25FZS84 competed?
The extent of competition for SPE2DB25FZS84 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award